Synteract Inks Buy of Harrison Clinical

Synteract, which is backed by Gryphon Investors, has agreed to buy Harrison Clinical Research. Financial terms were not announced. Munich, Germany-based Harrison is a clinical research company.

PEHUB Community

Join the 12493 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups